Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-090414
Filing Date
2019-03-28
Accepted
2019-03-28 16:00:33
Documents
4
Period of Report
2019-05-14
Effectiveness Date
2019-03-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d688201ddef14a.htm DEF 14A 356413
2 GRAPHIC g688201g11c64.jpg GRAPHIC 1169
3 GRAPHIC g688201g59n78.jpg GRAPHIC 1199
4 GRAPHIC g688201img5.jpg GRAPHIC 1579
  Complete submission text file 0001193125-19-090414.txt   363527
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 033-80623 | Film No.: 19711892
SIC: 2835 In Vitro & In Vivo Diagnostic Substances